Matthew Lewis

Matthew Lewis is an experienced professional in validation and project leadership within the pharmaceutical and biotechnology sectors. Currently serving as a C&Q Project Leader at Ipsen since April 2023, Matthew has a robust background that includes roles such as CQV Consultant at AstraZeneca and COVID-19 Vaccine Validation Lead at Wockhardt UK. Prior experience encompasses various validation and consultancy positions at notable companies, including RB, Briggs of Burton, and GSK, where responsibilities involved commissioning and qualification of production facilities, equipment, and processes to ensure compliance with regulatory standards. Matthew holds a Higher National Diploma in Natural Sciences from The Open University and has completed teacher training, further demonstrating a commitment to professional development in both technical and educational domains.